Cargando…

Impact of ideal versus estimated body weight on haemofiltration dosing in critically ill patients with AKI

Detalles Bibliográficos
Autores principales:	Fischer, F, Putignano, A, Willars, C, Wendon, J, Harris, S, Auzinger, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069572/ http://dx.doi.org/10.1186/cc13594

Ejemplares similares

Retrospective study of continuous haemofiltration on patients with acute liver failure with renal dysfunction
por: Antoniades, H, et al.
Publicado: (2003)

Oseltamivir dosing with haemofiltration
por: Tomlin, M, et al.
Publicado: (2010)

Retrospective study of the effect of haemofiltration on the outcome of patients with chronic liver disease with renal dysfunction
por: Antoniou, A, et al.
Publicado: (2003)

High-dose versus low-dose haemofiltration for the treatment of critically ill patients with acute kidney injury: an updated systematic review and meta-analysis
por: Li, Peng, et al.
Publicado: (2017)

High-volume continuous veno-venous haemofiltration in hyper-acute liver failure: a pilot study
por: Bernal, W, et al.
Publicado: (1999)

Actual versus ideal body weight for acute kidney injury diagnosis and classification in critically Ill patients
por: Thongprayoon, Charat, et al.
Publicado: (2014)

Nutrition Support in Critically Ill Patients with AKI
por: Ramakrishnan, Nagarajan, et al.
Publicado: (2020)

Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno‐venous haemofiltration
por: Selig, Daniel J., et al.
Publicado: (2021)

Economic argument for citrate haemofiltration
por: Patterson, J, et al.
Publicado: (2011)

Continuous venovenous haemofiltration in neonates
por: Mayell, S, et al.
Publicado: (2004)

Fluid accumulation increases the risk of AKI progression and death in critically ill patients with early AKI
por: Raimundo, MR, et al.
Publicado: (2014)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

Accuracy of Patient Height, Weight and Ideal Body Weight Estimates in the Emergency Department
por: Boehm, Kevin, et al.
Publicado: (2017)

Continuous haemofiltration in the intensive care unit
por: Bellomo, Rinaldo, et al.
Publicado: (2000)

Clearance of Sotalol on continuous venovenous haemofiltration
por: Roberts, H, et al.
Publicado: (2005)

402 Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
por: Frippiat, Frédéric, et al.
Publicado: (2014)

Management of sodium disorders during continuous haemofiltration
por: Ostermann, Marlies, et al.
Publicado: (2010)

An in vitro study of elimination of oseltamivir carboxylate by haemofiltration
por: Gruber, P, et al.
Publicado: (2007)

How continuous is continuous veno-venous haemofiltration?
por: Seidel, J, et al.
Publicado: (2006)

Hepatic drug metabolism by CYP2D6 in critically ill adults with AKI: effect of phenotype and AKI severity
por: Lane, K, et al.
Publicado: (2015)

Evaluation of Factors Associated with Hypermetabolism and Hypometabolism in Critically Ill AKI Patients
por: de Góes, Cassiana R., et al.
Publicado: (2018)

Urine Complement Factor Ba Is Associated with AKI in Critically Ill Children
por: Stenson, Erin K., et al.
Publicado: (2023)

Intermittent high-volume predilution on-line haemofiltration versus standard intermittent haemodialysis in critically ill patients with acute kidney injury: a prospective randomized study
por: Škofic, Nataša, et al.
Publicado: (2012)

Extracorporeal membrane oxygenation before and after adult liver transplantation: worth the effort?
por: Auzinger, G, et al.
Publicado: (2014)

Mass Transfer Characteristics of Haemofiltration Modules—Experiments and Modeling
por: Moschona, Alexandra, et al.
Publicado: (2022)

Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients
por: Ghasemiyeh, Parisa, et al.
Publicado: (2023)

Sugammadex and Ideal Body Weight in Bariatric Surgery
por: Sanfilippo, Maria, et al.
Publicado: (2013)

Assessment of adductor pollicis muscle function in critically ill patients
por: Harris, ML, et al.
Publicado: (1999)

Adequacy of haemodialysis and or haemofiltration treatments for patients with acute kidney injury
por: Davenport, Andrew
Publicado: (2010)

Combination of plasma exchange and haemofiltration for treating thrombotic microangiopathy in children
por: Huang, Jun, et al.
Publicado: (2020)

Predictors of fluid responsiveness in patients with acute liver failure
por: Audimoolam, VK, et al.
Publicado: (2011)

Evaluation of the predilution technique in reducing the occurrence of bleeding during continuous venovenous haemofiltration in critically ill patients. Efficacy of predilution in reducing the amount of anticoagulation during CVVH
por: Honore, PM, et al.
Publicado: (1997)

Pharmacokinetics of Sugammadex Dosed by Actual and Ideal Body Weight in Patients With Morbid Obesity Undergoing Surgery
por: Mostoller, Kate, et al.
Publicado: (2020)

NT-proBNP and troponin I in acute liver failure: do they predict cardiac dysfunction?
por: Mcphail, M, et al.
Publicado: (2011)

ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
por: Truche, A. S., et al.
Publicado: (2018)

Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes
por: Collett, Jason A., et al.
Publicado: (2022)

Neurological Impairment in Critically Ill Patients on Dialysis: Research Letter for the INCOGNITO-AKI Feasibility Study
por: Jawa, Natasha A., et al.
Publicado: (2023)

Patient Perception of Ideal Body Weight and the Effect of Body Mass Index
por: Naghshizadian, Rozhin, et al.
Publicado: (2014)

Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients
por: Schilder, Louise, et al.
Publicado: (2014)

Meropenem clearance by continuous haemofiltration: a comparison of in vivo and in vitro data
por: Giles, LJ, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_l0iidqf5qjnksml2jm31mvbjgo